Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Anderson

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Applied Neuropsychology. Adult|March 10, 2020
A comparison between the neurocognitive profile of Huntington Disease-Like 2 and Huntington Disease: Exploring the presence of double dissociationsAline Ferreira-Correia, David G Anderson, Kate Cockcroft, et al.
Methodsx|February 6, 2020
Single case-control design for the study of the neuropsychological deficits and dissociations in Huntington's disease-like 2Aline Ferreira-Correia, David G Anderson, Kate Cockcroft, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2008
Southeastern data inconsistent with Paleoindian demographic reconstructionDavid G Anderson, Scott C Meeks, Albert C Goodyear, et al.
Ecology and Evolution|September 15, 2017
Maintaining genetic integrity of coexisting wild and domestic populations: Genetic differentiation between wild and domestic <i>Rangifer</i> with long traditions of intentional interbreedingDavid G Anderson, Kjersti S Kvie, Vladimir N Davydov, et al.
Chemical Research in Toxicology|September 25, 2007
Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediateJennifer N Rees, Virginia R Florang, David G Anderson, et al.
The Journal of Biological Chemistry|June 7, 2011
Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinoneDavid G Anderson, S V Santhana Mariappan, Garry R Buettner, et al.
Neurogenetics|September 8, 2019
Frequency of the LRRK2 G2019S mutation in South African patients with Parkinson's diseaseNicola du Toit, Riaan van Coller, David G Anderson, et al.
Molecular Genetics & Genomic Medicine|April 1, 2017
A molecular analysis of the <i>GBA</i> gene in Caucasian South Africans with Parkinson's diseaseMelinda Barkhuizen, David G Anderson, Francois H van der Westhuizen, et al.
Plos One|February 8, 2019
Faecal biomarkers can distinguish specific mammalian species in modern and past environmentsLoïc Harrault, Karen Milek, Emilie Jardé, et al.
Journal of Huntington'S Disease|March 25, 2017
A Systematic Review of the Huntington Disease-Like 2 PhenotypeDavid G Anderson, Ruth H Walker, Myles Connor, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Applied Neuropsychology. Adult|March 10, 2020
A comparison between the neurocognitive profile of Huntington Disease-Like 2 and Huntington Disease: Exploring the presence of double dissociationsAline Ferreira-Correia, David G Anderson, Kate Cockcroft, et al.
Methodsx|February 6, 2020
Single case-control design for the study of the neuropsychological deficits and dissociations in Huntington's disease-like 2Aline Ferreira-Correia, David G Anderson, Kate Cockcroft, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2008
Southeastern data inconsistent with Paleoindian demographic reconstructionDavid G Anderson, Scott C Meeks, Albert C Goodyear, et al.
Ecology and Evolution|September 15, 2017
Maintaining genetic integrity of coexisting wild and domestic populations: Genetic differentiation between wild and domestic <i>Rangifer</i> with long traditions of intentional interbreedingDavid G Anderson, Kjersti S Kvie, Vladimir N Davydov, et al.
Chemical Research in Toxicology|September 25, 2007
Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediateJennifer N Rees, Virginia R Florang, David G Anderson, et al.
The Journal of Biological Chemistry|June 7, 2011
Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinoneDavid G Anderson, S V Santhana Mariappan, Garry R Buettner, et al.
Neurogenetics|September 8, 2019
Frequency of the LRRK2 G2019S mutation in South African patients with Parkinson's diseaseNicola du Toit, Riaan van Coller, David G Anderson, et al.
Molecular Genetics & Genomic Medicine|April 1, 2017
A molecular analysis of the <i>GBA</i> gene in Caucasian South Africans with Parkinson's diseaseMelinda Barkhuizen, David G Anderson, Francois H van der Westhuizen, et al.
Plos One|February 8, 2019
Faecal biomarkers can distinguish specific mammalian species in modern and past environmentsLoïc Harrault, Karen Milek, Emilie Jardé, et al.
Journal of Huntington'S Disease|March 25, 2017
A Systematic Review of the Huntington Disease-Like 2 PhenotypeDavid G Anderson, Ruth H Walker, Myles Connor, et al.
Pageof 6